FUDR/Oxaliplatin hepatic arterial infusion
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for FUDR/Oxaliplatin hepatic arterial infusion, covering 2023-02-16 to 2023-02-16. Get the full timeline:
Most recent: Clinical Trial Update: FUDR/Oxaliplatin HAI Plus Irinotecan vs. FOLFOXIRI Chemotherapy in Treating Initially Unresectable CRCLM [Phase 3]